We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

41 hedge funds and large institutions have $2.35M invested in Carisma Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

11% more funds holding

Funds holding: 37 → 41 (+4)

0.94% more ownership

Funds ownership: 12.53% → 13.47% (+0.94%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

54% less capital invested

Capital invested by funds: $5.11M → $2.35M (-$2.76M)

Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
5
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$30.4K
2
Renaissance Technologies
Renaissance Technologies
New York
+$20.3K
3
UBS Group
UBS Group
Switzerland
+$19.8K
4
Goldman Sachs
Goldman Sachs
New York
+$17.6K
5
LPL Financial
LPL Financial
California
+$17.2K

Top Sellers

Rank Fund Capital Flow
1
TGA
TPG GP A
Texas
-$551K
2
WC
Wexford Capital
Florida
-$34.2K
3
Two Sigma Investments
Two Sigma Investments
New York
-$33.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$24.2K
5
Millennium Management
Millennium Management
New York
-$18.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$2.08K – – –
Group One Trading
27
Group One Trading
Illinois
$934 – – –
JP Morgan Chase
28
JP Morgan Chase
New York
$386 – – –
UBP
29
Union Bancaire Privee
Switzerland
$227 +$441 +535 New
BTC
30
Bank & Trust Company
Illinois
$220 – – –
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$196 +$385 +467 New
PBK
32
Peoples Bank (Kansas)
Kansas
$102 – – –
IA
33
IFP Advisors
Florida
$86 – – –
OP
34
ORG Partners
Indiana
$83 – – –
CWA
35
Carolina Wealth Advisors
South Carolina
$63 +$124 +150 New
Osaic Holdings
36
Osaic Holdings
Arizona
$59 – – –
MWA
37
Medallion Wealth Advisors
Connecticut
$31 +$82 +100 New
National Bank of Canada
38
National Bank of Canada
Quebec, Canada
$21 -$95 -115 -70%
HI
39
Harbour Investments
Wisconsin
$15 – – –
SS
40
SBI Securities
Japan
$13 +$26 +31 New
Citigroup
41
Citigroup
New York
$4 – – –
TGA
42
TPG GP A
Texas
– -$551K -561,442 Closed
WC
43
Wexford Capital
Florida
– -$34.2K -34,861 Closed
Two Sigma Investments
44
Two Sigma Investments
New York
– -$33.5K -34,141 Closed
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
– -$16.3K -16,584 Closed
CFM
46
Catalyst Funds Management
Australia
– -$3.83K -3,900 Closed
Fidelity Investments
47
Fidelity Investments
Massachusetts
– -$722 -736 Closed
CPA
48
Capital Performance Advisors
California
– -$491 -500 Closed
Nisa Investment Advisors
49
Nisa Investment Advisors
Missouri
– -$158 -161 Closed
MWA
50
MFA Wealth Advisors
Pennsylvania
– -$8 -8 Closed
1
2

CARM Hedge Fund Activity: Q4 2024 in Review

41 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q4 2024, worth a combined $2.35M — down 54% from $5.11M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CARM positions and 9 closed out — a net gain of 5 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $30.4K. The largest seller was TPG GP A, exiting entirely with an estimated $551K sold.

  • 41 institutional investors held Carisma Therapeutics (CARM) as of Q4 2024, up from 37 in Q3 2024.
  • Funds reported $2.35M of Carisma Therapeutics stock for Q4 2024, down 54% quarter-over-quarter.
  • 14 funds opened new Carisma Therapeutics positions in Q4 2024 and 9 closed out, a net change of +5 holders.
  • The largest Carisma Therapeutics buyer in Q4 2024 was HRT Financial, an estimated $30.4K added.
  • The largest Carisma Therapeutics seller in Q4 2024 was TPG GP A, an estimated $551K sold.

Based on aggregated 13F filings for Q4 2024.